We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: Graphical abstract (Usyk M., Hayes R., Knight R. et al., Cell (2026). DOI: 10.1016/j.cell.2026.03.041)

Gut Microbiome Test Predicts Melanoma Recurrence After Surgery

A new microbiome fingerprint test predicts melanoma recurrence pre-treatment with up to 94% accuracy, enabling risk stratification. More...
22 Apr 2026
Image: The model analyzes routinely collected pathology slides to detect complex tissue features associated with immunotherapy response in metastatic NSCLC (photo courtesy of Shutterstock)

AI Pathology Model Predicts Immunotherapy Response in Lung Cancer

An AI pathomics system stratifies metastatic NSCLC by progression risk on immunotherapy using routine slides. More...
22 Apr 2026
Image: Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin lymphoma and often presents with aggressive clinical behavior (photo courtesy of Shutterstock)

Prognostic Biomarker Identified in Diffuse Large B-Cell Lymphoma

Researchers identify biological "off switch" in DLBCL that could serve as a prognostic marker. More...
22 Apr 2026
Image: Graphical abstract (Usyk M., Hayes R., Knight R. et al., Cell (2026). DOI: 10.1016/j.cell.2026.03.041)

Gut Microbiome Test Predicts Melanoma Recurrence After Surgery

A new microbiome fingerprint test predicts melanoma recurrence pre-treatment with up to 94% accuracy, enabling risk stratification. More...
21 Apr 2026
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

A machine learning approach profiles CpG methylation to infer tumor origin in CUP with ~95% accuracy. More...
21 Apr 2026
Image: Graphical abstract (Robinson S, Haile B, Reily-Bell M et al, Cell Reports Medicine (2026). DOI: 10.1016/j.xcrm.2026.102744)

Blood Test Enables Early Detection and Classification of Glioma

A new noninvasive sEV blood test detects gliomas early with high accuracy and distinguishes subtypes to guide therapy. More...
21 Apr 2026
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

A new urine-based MCED gains FDA Breakthrough to enable early detection of more than 10 cancers from a single sample. More...
21 Apr 2026
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA